Adamantan-1-amine

Catalog No.: 
ACWHKO418
CAS No.: 
768-94-5
Molecular Formula: 
C10H17N
Molecular Weight: 
151.25
Adamantan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g99%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAdamantan-1-amine
IUPAC Nameadamantan-1-amine
MDL No.MFCD00074732
Molecular FormulaC10H17N
Molecular Weight151.25
SMILESNC12CC3CC(C2)CC(C3)C1
InChI KeyDKNWSYNQZKUICI-UHFFFAOYSA-N
SynonymSymadine | 1-Adamantamine | Pk-merz | adamantan-1-amine | Adamantanamine | amantadine | Amantidine | Adamantamine | Amantadina | adamantan-1-ylamine | Amantadinum | 1-Aminoadamantane | Aminoadamantane | Adamantylamine
CAS No.768-94-5
PubChem CID2130

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWHKO418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVYEQ678 route compound structure diagram
    ACVYEQ678281-23-2In Stock
  2. Then
  3. ACWHKO418 route product structure diagram
    ACWHKO418768-94-5In Stock
Inquiry

2. ACWHKO418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Plus
  5. ACWHKO418 route compound structure diagram
    ACWHKO418768-94-5In Stock
  6. Then
  7. ACWHKO418 route product structure diagram
    ACWHKO418768-94-5In Stock
Inquiry

3. ACWHKO418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  4. Then
  5. ACWHKO418 route product structure diagram
    ACWHKO418768-94-5In Stock
Inquiry

Comments (0)